Sindhu Chandran, MBBS

Sindhu Chandran practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Sindhu Chandran's NPI, 1598951014, was assigned on September 18, 2007. Sindhu Chandran graduated from All India Institute of Medical Sciences in 2002. Sindhu Chandran holds California license A97616.

Sindhu Chandran's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Sindhu Chandran's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Sindhu Chandran to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sindhu Chandran practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Sindhu Chandran's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Sindhu Chandran is board certified in internal medicine by the American Board of Internal Medicine. Sindhu Chandran is licensed in California.

Dmand AI lists chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Sindhu Chandran treats.

CMS data shows 462 Medicare services from Sindhu Chandran across 4 procedure codes in 2024, for 288 Medicare patients. Medicare paid $47,947 for them.

CMS counts 288 Medicare patients who saw Sindhu Chandran in 2024. The largest group is under 65, with 155 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 57% are also on Medicaid. Their average risk score is 6.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sindhu Chandran's median patient age at 59, with 40% women.

In 2024, Sindhu Chandran wrote 1,273 Medicare Part D claims for 233 patients. 84% of them were for generic drugs. CMS names the drug for 1,009 of them, across 28 drugs with 11 or more claims each, at $90,407 in total drug cost. In 2023, CMS named 696 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Sindhu Chandran for performance year 2024, reported as part of a group. Sindhu Chandran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 49 papers to Sindhu Chandran, published from 2011 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Kidney Transplantation, Graft Rejection and Immunosuppressive Agents. Sindhu Chandran has published most often in Am J Transplant. Sindhu Chandran's most frequent co-authors are David M. Wojciechowski, DO, Minnie M. Sarwal, MD, PhD and Sandy Feng, MD.

Dmand AI links Sindhu Chandran to 5 clinical trials, 2 of them phase 1/2 studies. Conditions studied include HIV Infections, Inflammation and Lentivirus Infections. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 3.

CMS Open Payments shows 5 general payments to Sindhu Chandran from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $207.

Dmand AI lists 1 award for Sindhu Chandran, most recently CMS Stage 1 EHR in 2013.

Sindhu Chandran graduated from All India Institute of Medical Sciences in 2002. Sindhu Chandran is a member of ASN and American Society of Transplantation.

Sindhu Chandran is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.